Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/19 17:50 | 11/18/19 | REPL | Health | BioPrd | Biological Products, (No Diag | Rhodes Jason P | MA | D | P | 14,971 | 13.61 | 0 | 1,100 | 29 | 4,935 | I | |||||||||||||||
11/20/19 12:36 | 11/18/19 | REPL | Health | BioPrd | Biological Products, (No Diag | Omega Fund Iv, L.P. | MA | T | P | 2,994 | 13.61 | 0 | 220 | 4 | 5,329 | D | |||||||||||||||
7/26/18 17:26 | 7/24/18 | REPL | Health | BioPrd | Biological Products, (No Diag | Slootweg Hugo Alexander | MA | DT | P.d | 2,000 | 15.00 | 0 | 133 | 3 | 4,721 | I | |||||||||||||||
7/26/18 17:16 | 7/24/18 | REPL | Health | BioPrd | Biological Products, (No Diag | Slattery Joseph P | MA | D | P.d | 100 | 15.00 | 0 | 7 | New | 7 | D | |||||||||||||||
7/26/18 17:16 | 7/24/18 | REPL | Health | BioPrd | Biological Products, (No Diag | Forbion Capital Fund III Cooperatief U.A. | P7 | T | P.d | 2,000 | 15.00 | 0 | 133 | 3 | 4,721 | I | |||||||||||||||
7/26/18 16:27 | 7/24/18 | REPL | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | P.d | 7,500 | 15.00 | 0 | 500 | 21 | 2,839 | I | |||||||||||||||
7/25/18 17:09 | 7/24/18 | REPL | Health | BioPrd | Biological Products, (No Diag | Omega Fund Iv, L.P. | MA | T | P.d | 4,000 | 15.00 | 0 | 267 | 6 | 4,855 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |